We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3549:TSEKUSURI NO AOKI HOLDINGS CO.,LTD. Analysis

Data as of 2026-06-07 - not real-time

¥3,647.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kusuri No Aoki Holdings is trading at 3,647 JPY, well below its 20‑day, 50‑day and 200‑day simple moving averages, signalling a bearish price environment. The 30‑day volatility sits near 30%, indicating sizable price swings. A negative beta close to zero suggests the stock moves independently of the broader market, reducing systematic risk. Technical momentum is mixed: the MACD histogram has turned positive while the RSI hovers around the 50‑point neutral zone. Support is identified around 3,351 JPY and resistance near 3,914 JPY, framing the current price within a modest upside corridor. Fundamentally, the trailing P/E of roughly 19.5 is well under the industry average of 27.9, pointing to a valuation gap.
The company delivers 10% revenue growth and maintains a low dividend payout ratio of about 8%, supporting dividend sustainability. Cash reserves exceed 51 billion JPY, though debt levels are high, resulting in a debt‑to‑equity around 100%. The forward P/E compresses to 17.8, reinforcing the undervalued narrative. Analyst consensus remains neutral with a “hold” recommendation, while target prices imply roughly a 6‑7% upside. Given the stable trading volume and defensive healthcare exposure, liquidity risk is limited. Overall, the stock presents a modest upside opportunity for patient investors willing to navigate short‑term bearish pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price below all major moving averages indicating bearish bias
  • high 30‑day volatility may trigger sharp moves
  • proximity to identified support level at 3,351 JPY

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • trailing P/E well below industry average suggesting valuation upside
  • revenue growth of 10% and low dividend payout support earnings momentum
  • target price median of 3,830 JPY provides ~6% upside

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustainable dividend backed by low payout ratio
  • strong cash balance offsets high debt concerns over time
  • healthcare retail sector offers defensive, steady demand

Key Metrics & Analysis

Financial Health

Revenue Growth10.80%
Profit Margin3.48%
P/E Ratio19.5
ROE13.46%
ROA4.78%
Debt/Equity100.78
P/B Ratio2.5
Industry P/E27.9

Technical Analysis

TrendBearish
RSI49.9
Support¥3,351.00
Resistance¥3,914.00
MA 20¥3,656.45
MA 50¥3,733.72
MA 200¥3,929.11
MACDBullish
VolumeStable
Fear & Greed Index83.02

Valuation

Target Price¥3,896.00
Upside/Downside6.83%
GradeUndervalued
TypeBlend
Dividend Yield0.44%

Risk Assessment

Beta-0.22
Volatility29.61%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.